AVENUE THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $0.00.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $55.00K, a 93.35% decline from fiscal 2024.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $827.00K, a 1048.61% increase from fiscal 2023.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $72.00K.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $55.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $339.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $339.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $55.00K 10-Q · filed 2026-05-08 | $511.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $827.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $543.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $172.00K 10-Q · filed 2025-08-14 | $543.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $371.00K 10-Q · filed 2025-05-15 | $371.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $72.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | |
| 2023-03-31 | $72.00K 10-Q · filed 2024-05-15 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-13 | $948.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $948.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $948.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $5.00K 10-K · filed 2018-03-01 |